Titan Pharmaceuticals, Inc.
TTNP
$4.99
$0.091.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.80M | 1.95M | 2.83M | 3.40M | 4.09M |
| Total Receivables | 143.00K | 81.00K | 62.00K | 52.00K | 38.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 105.00K | 130.00K | 30.00K | 151.00K | 220.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.05M | 2.16M | 2.92M | 3.60M | 4.35M |
|
|
|||||
| Total Current Assets | 3.05M | 2.16M | 2.92M | 3.60M | 4.35M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.05M | 2.16M | 2.92M | 3.60M | 4.35M |
|
|
|||||
| Total Accounts Payable | 219.00K | 194.00K | 202.00K | 371.00K | 356.00K |
| Total Accrued Expenses | 44.00K | 85.00K | 281.00K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 263.00K | 279.00K | 483.00K | 371.00K | 356.00K |
|
|
|||||
| Total Current Liabilities | 263.00K | 279.00K | 483.00K | 371.00K | 356.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 263.00K | 279.00K | 483.00K | 371.00K | 356.00K |
|
|
|||||
| Common Stock & APIC | 400.58M | 398.98M | 398.98M | 398.98M | 398.98M |
| Retained Earnings | -397.79M | -397.10M | -396.54M | -395.75M | -394.98M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.79M | 1.88M | 2.44M | 3.23M | 3.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | 1.00K | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | 2.79M | 1.88M | 2.44M | 3.23M | 3.99M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.79M | 1.88M | 2.44M | 3.23M | 3.99M |
|
|
|||||